179 related articles for article (PubMed ID: 15867344)
1. Implication of galectin-3 in Wnt signaling.
Shimura T; Takenaka Y; Fukumori T; Tsutsumi S; Okada K; Hogan V; Kikuchi A; Kuwano H; Raz A
Cancer Res; 2005 May; 65(9):3535-7. PubMed ID: 15867344
[TBL] [Abstract][Full Text] [Related]
2. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
[TBL] [Abstract][Full Text] [Related]
3. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
[TBL] [Abstract][Full Text] [Related]
4. Galectin-3 mediates nuclear beta-catenin accumulation and Wnt signaling in human colon cancer cells by regulation of glycogen synthase kinase-3beta activity.
Song S; Mazurek N; Liu C; Sun Y; Ding QQ; Liu K; Hung MC; Bresalier RS
Cancer Res; 2009 Feb; 69(4):1343-9. PubMed ID: 19190323
[TBL] [Abstract][Full Text] [Related]
5. Glycogen synthase kinase-3 and Axin function in a beta-catenin-independent pathway that regulates neurite outgrowth in neuroblastoma cells.
Orme MH; Giannini AL; Vivanco MD; Kypta RM
Mol Cell Neurosci; 2003 Nov; 24(3):673-86. PubMed ID: 14664817
[TBL] [Abstract][Full Text] [Related]
6. Galectin-3, a novel binding partner of beta-catenin.
Shimura T; Takenaka Y; Tsutsumi S; Hogan V; Kikuchi A; Raz A
Cancer Res; 2004 Sep; 64(18):6363-7. PubMed ID: 15374939
[TBL] [Abstract][Full Text] [Related]
7. Wnt-induced dephosphorylation of axin releases beta-catenin from the axin complex.
Willert K; Shibamoto S; Nusse R
Genes Dev; 1999 Jul; 13(14):1768-73. PubMed ID: 10421629
[TBL] [Abstract][Full Text] [Related]
8. The proinvasive activity of Wnt-2 is mediated through a noncanonical Wnt pathway coupled to GSK-3beta and c-Jun/AP-1 signaling.
Le Floch N; Rivat C; De Wever O; Bruyneel E; Mareel M; Dale T; Gespach C
FASEB J; 2005 Jan; 19(1):144-6. PubMed ID: 15507471
[TBL] [Abstract][Full Text] [Related]
9. The calpain system is involved in the constitutive regulation of beta-catenin signaling functions.
Benetti R; Copetti T; Dell'Orso S; Melloni E; Brancolini C; Monte M; Schneider C
J Biol Chem; 2005 Jun; 280(23):22070-80. PubMed ID: 15817486
[TBL] [Abstract][Full Text] [Related]
10. Axil, a member of the Axin family, interacts with both glycogen synthase kinase 3beta and beta-catenin and inhibits axis formation of Xenopus embryos.
Yamamoto H; Kishida S; Uochi T; Ikeda S; Koyama S; Asashima M; Kikuchi A
Mol Cell Biol; 1998 May; 18(5):2867-75. PubMed ID: 9566905
[TBL] [Abstract][Full Text] [Related]
11. Activation of the canonical Wnt/beta-catenin pathway confers growth advantages in c-Myc/E2F1 transgenic mouse model of liver cancer.
Calvisi DF; Conner EA; Ladu S; Lemmer ER; Factor VM; Thorgeirsson SS
J Hepatol; 2005 Jun; 42(6):842-9. PubMed ID: 15885355
[TBL] [Abstract][Full Text] [Related]
12. Axin negatively affects tau phosphorylation by glycogen synthase kinase 3beta.
Stoothoff WH; Bailey CD; Mi K; Lin SC; Johnson GV
J Neurochem; 2002 Nov; 83(4):904-13. PubMed ID: 12421363
[TBL] [Abstract][Full Text] [Related]
13. Structural basis for recruitment of glycogen synthase kinase 3beta to the axin-APC scaffold complex.
Dajani R; Fraser E; Roe SM; Yeo M; Good VM; Thompson V; Dale TC; Pearl LH
EMBO J; 2003 Feb; 22(3):494-501. PubMed ID: 12554650
[TBL] [Abstract][Full Text] [Related]
14. Axin-mediated CKI phosphorylation of beta-catenin at Ser 45: a molecular switch for the Wnt pathway.
Amit S; Hatzubai A; Birman Y; Andersen JS; Ben-Shushan E; Mann M; Ben-Neriah Y; Alkalay I
Genes Dev; 2002 May; 16(9):1066-76. PubMed ID: 12000790
[TBL] [Abstract][Full Text] [Related]
15. Cyclin-dependent kinase 2 regulates the interaction of Axin with beta-catenin.
Kim SI; Park CS; Lee MS; Kwon MS; Jho EH; Song WK
Biochem Biophys Res Commun; 2004 Apr; 317(2):478-83. PubMed ID: 15063782
[TBL] [Abstract][Full Text] [Related]
16. Aberrant beta-catenin signaling in tuberous sclerosis.
Mak BC; Kenerson HL; Aicher LD; Barnes EA; Yeung RS
Am J Pathol; 2005 Jul; 167(1):107-16. PubMed ID: 15972957
[TBL] [Abstract][Full Text] [Related]
17. Morphological and transcriptional responses of untransformed intestinal epithelial cells to an oncogenic beta-catenin protein.
Naishiro Y; Yamada T; Idogawa M; Honda K; Takada M; Kondo T; Imai K; Hirohashi S
Oncogene; 2005 Apr; 24(19):3141-53. PubMed ID: 15735679
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of beta-catenin by p53 involves changes in the rate of beta-catenin phosphorylation and Axin dynamics.
Levina E; Oren M; Ben-Ze'ev A
Oncogene; 2004 May; 23(25):4444-53. PubMed ID: 15064706
[TBL] [Abstract][Full Text] [Related]
19. Peutz-Jeghers LKB1 mutants fail to activate GSK-3beta, preventing it from inhibiting Wnt signaling.
Lin-Marq N; Borel C; Antonarakis SE
Mol Genet Genomics; 2005 Apr; 273(2):184-96. PubMed ID: 15731909
[TBL] [Abstract][Full Text] [Related]
20. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
